[LGND] YoY Annual Result on 31-Dec-2016 [#FY]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
28-Feb-2017
Financial Year
2016
Quarter
31-Dec-2016 [#FY]
Profit Trend
YoY- -100.64%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Annual Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 120,282 251,453 141,102 108,973 71,914 64,538 48,974 16.14%
PBT 796,639 173,330 57,231 7,960 35,329 11,302 9,207 110.23%
Tax 167,337 30,009 44,675 10,327 -219,596 410 374 176.42%
NP 629,302 143,321 12,556 -1,636 257,305 12,024 11,421 95.01%
Tax Rate -21.01% -17.31% -78.06% -129.74% 621.57% -3.63% -4.06% -
Total Cost -509,020 108,132 128,546 110,609 -185,391 52,514 37,553 -
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin 523.19 57.00 8.90 -1.50 357.80 18.63 23.32 67.90%
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS 33.13 5.96 0.60 -0.08 13.00 0.59 0.56 97.33%
EPS Diluted 31.85 5.96 0.53 -0.08 12.12 0.56 0.55 96.63%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.